WallStreetZenWallStreetZen

NASDAQ: ASMB
Assembly Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ASMB

Based on 4 analysts offering 12 month price targets for Assembly Biosciences Inc

Min Forecast
$43.00+111.82%
Avg Forecast
$47.50+133.99%
Max Forecast
$52.00+156.16%

Should I buy or sell ASMB stock?

Based on 4 analysts offering ratings for Assembly Biosciences Inc.

Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ASMB's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ASMB as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their ASMB stock forecasts and price targets.

ASMB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-01
lockedlocked$00.00+00.00%2026-09-01
lockedlocked$00.00+00.00%2026-08-18
lockedlocked$00.00+00.00%2026-05-28

1 of 1

Forecast return on equity

Is ASMB forecast to generate an efficient return?

Company
-21.02%
Industry
21.47%
Market
176.3%
ASMB's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ASMB forecast to generate an efficient return on assets?

Company
-19.42%
Industry
23.1%
ASMB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ASMB earnings per share forecast

What is ASMB's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$2.04-300%
Avg 2 year Forecast
-$4.44-535%
Avg 3 year Forecast
-$2.39-334.5%

ASMB revenue forecast

What is ASMB's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$32.2M
Avg 2 year Forecast
$34.8M
Avg 3 year Forecast
$49.8M

ASMB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ASMB$20.30$47.50+133.99%Strong Buy
AUTL$1.55$10.00+545.16%Buy
AGMB$8.40$43.00+411.90%Strong Buy
ZURA$4.27$21.00+391.80%Strong Buy
ALLO$1.23$6.00+387.80%Buy
View Top Biotech Stocks

Assembly Biosciences Stock Forecast FAQ

Is Assembly Biosciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: ASMB) stock is to Strong Buy ASMB stock.

Out of 4 analysts, 2 (50%) are recommending ASMB as a Strong Buy, 2 (50%) are recommending ASMB as a Buy, 0 (0%) are recommending ASMB as a Hold, 0 (0%) are recommending ASMB as a Sell, and 0 (0%) are recommending ASMB as a Strong Sell.

If you're new to stock investing, here's how to buy Assembly Biosciences stock.

What is ASMB's earnings growth forecast for 2026-2028?

(NASDAQ: ASMB) Assembly Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.38%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.75%.

Assembly Biosciences's earnings in 2026 is -$42,000.On average, 7 Wall Street analysts forecast ASMB's earnings for 2026 to be -$41,535,616, with the lowest ASMB earnings forecast at -$51,280,197, and the highest ASMB earnings forecast at -$30,571,435. On average, 7 Wall Street analysts forecast ASMB's earnings for 2027 to be -$90,339,964, with the lowest ASMB earnings forecast at -$98,769,251, and the highest ASMB earnings forecast at -$80,169,847.

In 2028, ASMB is forecast to generate -$48,700,510 in earnings, with the lowest earnings forecast at -$66,644,303 and the highest earnings forecast at -$28,861,145.

What is ASMB's revenue growth forecast for 2026-2028?

(NASDAQ: ASMB) Assembly Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.4%.

Assembly Biosciences's revenue in 2026 is $0.On average, 7 Wall Street analysts forecast ASMB's revenue for 2026 to be $655,896,240, with the lowest ASMB revenue forecast at $430,728,408, and the highest ASMB revenue forecast at $888,475,328. On average, 7 Wall Street analysts forecast ASMB's revenue for 2027 to be $708,589,462, with the lowest ASMB revenue forecast at $0, and the highest ASMB revenue forecast at $1,584,156,172.

In 2028, ASMB is forecast to generate $1,012,960,012 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $1,968,971,436.

What is ASMB's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ASMB) forecast ROA is -19.42%, which is lower than the forecast US Biotechnology industry average of 23.1%.

What is ASMB's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ASMB price target, the average ASMB price target is $47.50, with the highest ASMB stock price forecast at $52.00 and the lowest ASMB stock price forecast at $43.00.

On average, Wall Street analysts predict that Assembly Biosciences's share price could reach $47.50 by Sep 1, 2027. The average Assembly Biosciences stock price prediction forecasts a potential upside of 133.99% from the current ASMB share price of $20.30.

What is ASMB's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ASMB) Assembly Biosciences's current Earnings Per Share (EPS) is $1.02. On average, analysts forecast that ASMB's EPS will be -$2.04 for 2026, with the lowest EPS forecast at -$2.52, and the highest EPS forecast at -$1.50. On average, analysts forecast that ASMB's EPS will be -$4.44 for 2027, with the lowest EPS forecast at -$4.85, and the highest EPS forecast at -$3.94. In 2028, ASMB's EPS is forecast to hit -$2.39 (min: -$3.27, max: -$1.42).

What is ASMB's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ASMB) forecast ROE is -21.02%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.